Dandekar Mangal, Tseng Jeffrey R, Gambhir Sanjiv S
Department of Radiology and the Bio-X Program, Stanford University School of Medicine, Stanford, California, USA.
J Nucl Med. 2007 Apr;48(4):602-7. doi: 10.2967/jnumed.106.036608.
(18)F-FDG has been used to image mouse xenograft models with small-animal PET for therapy response. However, the reproducibility of serial scans has not been determined. The purpose of this study was to determine the reproducibility of (18)F-FDG small-animal PET studies.
Mouse tumor xenografts were formed with B16F10 murine melanoma cells. A 7-min small-animal PET scan was performed 1 h after a 3.7- to 7.4-MBq (18)F-FDG injection via the tail vein. A second small-animal PET scan was performed 6 h later after reinjection of (18)F-FDG. Twenty-five sets of studies were performed. Mean injected dose per gram (%ID/g) values were calculated from tumor regions of interest. The coefficient of variation (COV) from studies performed on the same day was calculated to determine the reproducibility. Activity from the second scans performed after 6 h were adjusted by subtracting the estimated residual activity from the first (18)F-FDG injection. For 7 datasets, an additional scan immediately before the second injection was performed, and residual activity from this additional delayed scan was subtracted from the activity of the second injection. COVs of both subtraction methods were compared. Blood glucose values were measured at the time of injection and used to correct the %ID/g values.
The COV for the mean %ID/g between (18)F-FDG small-animal PET scans performed on the same day 6 h apart was 15.4% +/- 12.6%. The delayed scan subtraction method did not produce any significant change in the COV. Blood glucose correction increased the COV. The injected dose, tumor size, and body weight did not appear to contribute to the variability of the scans.
(18)F-FDG small-animal PET mouse xenograft studies were reproducible with moderately low variability. Therefore, serial small-animal PET studies may be performed with reasonable accuracy to measure tumor response to therapy.
(18)F - FDG已用于通过小动物正电子发射断层显像(PET)对小鼠异种移植模型进行治疗反应成像。然而,连续扫描的可重复性尚未确定。本研究的目的是确定(18)F - FDG小动物PET研究的可重复性。
用B16F10小鼠黑色素瘤细胞形成小鼠肿瘤异种移植模型。经尾静脉注射3.7至7.4 MBq(18)F - FDG后1小时进行7分钟的小动物PET扫描。再次注射(18)F - FDG 6小时后进行第二次小动物PET扫描。共进行了25组研究。从肿瘤感兴趣区域计算每克平均注射剂量(%ID/g)值。计算同一天进行的研究的变异系数(COV)以确定可重复性。6小时后进行的第二次扫描的活性通过减去第一次(18)F - FDG注射的估计残留活性来调整。对于7个数据集,在第二次注射前立即进行额外扫描,并从第二次注射的活性中减去该额外延迟扫描的残留活性。比较两种减法方法的COV。在注射时测量血糖值并用于校正%ID/g值。
相隔6小时在同一天进行的(18)F - FDG小动物PET扫描之间的平均%ID/g的COV为15.4%±12.6%。延迟扫描减法方法在COV上未产生任何显著变化。血糖校正增加了COV。注射剂量、肿瘤大小和体重似乎对扫描的变异性没有影响。
(18)F - FDG小动物PET小鼠异种移植研究具有可重复性,变异性中等偏低。因此,可以以合理的准确性进行连续的小动物PET研究以测量肿瘤对治疗的反应。